medical device startup NICO Corp. announced it will introduce its first
commercial product today at the American Association of Neurological
Surgeons conference in
which stands for Neuro Interventional Co., was founded last year by a
core group of entrepreneurs who had previously formed medical-device
maker Suros Surgical Systems Inc., one of the fastest-growing companies
is attempting to commercialize a minimally-invasive device dubbed “the
Myriad” that can remove tumors and tissues from the human brain and
spine. The device is based on the same technology Suros used to create
its innovative equipment for automated-needle breast biopsies. NICO
licensed the technology from Suros’ purchaser, Bedford, Mass.-based
With the Myriad, NICO aims to help 200,000 people in the
Since inception, NICO has raised $2.8 million, some from Suros’ original group of 45 angel investors.
“The Myriad will help revolutionize the neuro and spine tumor removal market as we know it today,” said NICO CEO Jim Pearson.
Pearson said the device has been successfully used at several leading